Type | Description | Status | Start | End |
signal peptide | | | 1 | 18 |
chain | Serum albumin | | 25 | 609 |
disulfide bond | | | 77 | 86 |
disulfide bond | | | 99 | 115 |
disulfide bond | | | 114 | 125 |
disulfide bond | | | 148 | 193 |
disulfide bond | | | 192 | 201 |
disulfide bond | | | 224 | 270 |
disulfide bond | | | 269 | 277 |
disulfide bond | | | 289 | 303 |
disulfide bond | | | 302 | 313 |
disulfide bond | | | 340 | 385 |
disulfide bond | | | 384 | 393 |
disulfide bond | | | 416 | 462 |
disulfide bond | | | 461 | 472 |
disulfide bond | | | 485 | 501 |
disulfide bond | | | 500 | 511 |
disulfide bond | | | 538 | 583 |
disulfide bond | | | 582 | 591 |
domain | Albumin 1 | | 25 | 205 |
domain | Albumin 2 | | 212 | 397 |
domain | Albumin 3 | | 404 | 595 |
modified residue | Phosphoserine | | 82 | 82 |
modified residue | Phosphotyrosine | | 108 | 108 |
modified residue | Phosphotyrosine | | 164 | 164 |
glycosylation site | N-linked (Glc) (glycation) | probable | 36 | 36 |
glycosylation site | N-linked (Glc) (glycation); in vitro | | 75 | 75 |
glycosylation site | N-linked (Glc) (glycation); in vitro | | 161 | 161 |
glycosylation site | N-linked (Glc) (glycation); in vitro | | 186 | 186 |
glycosylation site | N-linked (Glc) (glycation); in vitro | | 223 | 223 |
glycosylation site | N-linked (Glc) (glycation); in vitro | | 249 | 249 |
glycosylation site | N-linked (Glc) (glycation) | probable | 257 | 257 |
glycosylation site | N-linked (Glc) (glycation); in vitro | | 300 | 300 |
glycosylation site | N-linked (Glc) (glycation) | | 305 | 305 |
glycosylation site | N-linked (Glc) (glycation); in vitro | | 337 | 337 |
glycosylation site | N-linked (Glc) (glycation) | probable | 341 | 341 |
glycosylation site | N-linked (GlcNAc...); in variant Redhill | | 342 | 342 |
glycosylation site | N-linked (Glc) (glycation); in vitro | | 347 | 347 |
glycosylation site | N-linked (Glc) (glycation) | probable | 375 | 375 |
glycosylation site | N-linked (Glc) (glycation); in vitro | | 402 | 402 |
glycosylation site | N-linked (Glc) (glycation); in vitro | | 437 | 437 |
glycosylation site | N-linked (Glc) (glycation) | | 463 | 463 |
glycosylation site | N-linked (Glc) (glycation); in vitro | | 468 | 468 |
glycosylation site | N-linked (GlcNAc...); in variant Casebrook | | 518 | 518 |
glycosylation site | N-linked (Glc) (glycation) | | 549 | 549 |
glycosylation site | N-linked (Glc) (glycation) | probable | 558 | 558 |
glycosylation site | N-linked (Glc) (glycation); in vitro | | 560 | 560 |
glycosylation site | N-linked (Glc) (glycation); in vitro | | 569 | 569 |
glycosylation site | N-linked (Glc) (glycation); in vitro | | 597 | 597 |
sequence variant | (in Nagoya) | | 0 | 0 |
sequence variant | (in Christchurch/Honolulu-2) | | 0 | 0 |
sequence variant | (in Herborn) | | 0 | 0 |
sequence variant | (in Nagasaki-3) | | 0 | 0 |
sequence variant | (in dbSNP:rs3210154) | | 0 | 0 |
sequence variant | (in Takefu/Honolulu-1) | | 0 | 0 |
sequence variant | (in Redhill/Malmo-I/Tradate; associated with T-344 in Redhill) | | 0 | 0 |
sequence variant | (in Hawkes bay) | | 0 | 0 |
sequence variant | (in Tregasio) | | 0 | 0 |
sequence variant | (in Komagome-2) | | 0 | 0 |
sequence variant | (in FDH) | | 0 | 0 |
sequence variant | (in Tradate-2) | | 0 | 0 |
sequence variant | (in Larino) | | 0 | 0 |
sequence variant | (in Jaffna) | | 0 | 0 |
sequence variant | (in Yanomama-2) | | 0 | 0 |
sequence variant | | | 0 | 0 |
sequence variant | (in Vibo Valentia) | | 0 | 0 |
sequence variant | (in FDH) | | 0 | 0 |
sequence variant | (in Malmo-95/Dalakarlia) | | 0 | 0 |
sequence variant | (in Torino) | | 0 | 0 |
sequence variant | (in dbSNP:rs3210163) | | 0 | 0 |
sequence variant | | | 0 | 0 |
sequence variant | (in dbSNP:rs3204504) | | 0 | 0 |
sequence variant | (in Malmo-10) | | 0 | 0 |
sequence variant | (in Fukuoka-2/Lille/Taipei/Varese/ Komagome-3) | | 0 | 0 |
sequence variant | (in FDH) | | 0 | 0 |
sequence variant | (in Kenitra) | | 0 | 0 |
sequence variant | (in Maddaloni) | | 0 | 0 |
sequence variant | (in Ortonovo) | | 0 | 0 |
sequence variant | (in Manaus-1/Adana/Lambadi/ Vancouver) | | 0 | 0 |
sequence variant | (in Casebrook) | | 0 | 0 |
sequence variant | (in Dublin) | | 0 | 0 |
sequence variant | (in Bleinheim/Iowa city-2) | | 0 | 0 |
sequence variant | (in dbSNP:rs1063469) | | 0 | 0 |
sequence variant | (in Liprizzi) | | 0 | 0 |
sequence variant | (in Castel di Sangro) | | 0 | 0 |
sequence variant | (in Maku) | | 0 | 0 |
sequence variant | (in Vanves) | | 0 | 0 |
sequence variant | (in Gent/Milano Fast) | | 0 | 0 |
sequence variant | (in Venezia) | | 0 | 0 |
sequence variant | (in Osaka-2/Phnom Phen/albumin B/ Verona) | | 0 | 0 |
sequence variant | (in Osaka-1) | | 0 | 0 |
sequence variant | (in Fukuoka-1/Paris-2) | | 0 | 0 |
sequence variant | (in Mexico) | | 0 | 0 |
sequence variant | (in Malmo-61) | | 0 | 0 |
sequence variant | | | 0 | 0 |
sequence variant | (in Hiroshima-2) | | 0 | 0 |
sequence variant | (in Redhill; associated with C- 23) | | 0 | 0 |
sequence variant | (in Malmo-47) | | 0 | 0 |
sequence variant | (in Brest) | | 0 | 0 |
sequence variant | (in Bergamo) | | 0 | 0 |
sequence variant | (in Caserta) | | 0 | 0 |
sequence variant | (in Nagasaki-1) | | 0 | 0 |
sequence variant | (in Church bay) | | 0 | 0 |
sequence variant | (in Canterbury/New Guinea/ Tagliacozzo/Cuneo/Cooperstown) | | 0 | 0 |
sequence variant | (in Roma) | | 0 | 0 |
sequence variant | (in Sondrio) | | 0 | 0 |
sequence variant | (in Hiroshima-1) | | 0 | 0 |
sequence variant | (in Malmo-5) | | 0 | 0 |
sequence variant | (in Tochigi) | | 0 | 0 |
sequence variant | (in Nagasaki-2) | | 0 | 0 |
sequence variant | (in Naskapi/Mersin/Komagome-1) | | 0 | 0 |
sequence variant | (in Iowa city-1) | | 0 | 0 |
sequence variant | (in Parklands) | | 0 | 0 |
sequence variant | (in Trieste) | | 0 | 0 |
sequence variant | (in Coari I/Porto Alegre) | | 0 | 0 |
strand | | | 83 | 85 |
strand | | | 195 | 197 |
strand | | | 561 | 563 |
helix | | | 31 | 54 |
helix | | | 60 | 79 |
helix | | | 90 | 102 |
helix | | | 105 | 108 |
helix | | | 111 | 115 |
helix | | | 124 | 128 |
helix | | | 144 | 153 |
helix | | | 155 | 167 |
helix | | | 175 | 192 |
helix | | | 198 | 230 |
helix | | | 232 | 246 |
helix | | | 252 | 271 |
helix | | | 274 | 290 |
helix | | | 292 | 295 |
helix | | | 300 | 303 |
helix | | | 307 | 314 |
helix | | | 330 | 333 |
helix | | | 339 | 345 |
helix | | | 347 | 360 |
helix | | | 367 | 385 |
helix | | | 390 | 393 |
helix | | | 394 | 397 |
helix | | | 398 | 438 |
helix | | | 444 | 461 |
helix | | | 466 | 490 |
helix | | | 495 | 503 |
helix | | | 508 | 514 |
helix | | | 528 | 530 |
helix | | | 535 | 539 |
helix | | | 542 | 559 |
helix | | | 567 | 584 |
helix | | | 591 | 605 |
site | Not glycated | | 28 | 28 |
site | Not glycated | | 44 | 44 |
site | Not glycated | | 65 | 65 |
site | Not glycated | | 88 | 88 |
site | Not glycated | | 97 | 97 |
site | Not glycated | | 117 | 117 |
site | Not glycated | | 130 | 130 |
site | Not glycated | | 160 | 160 |
site | Not glycated | | 183 | 183 |
site | Not glycated | | 198 | 198 |
site | Not glycated | | 205 | 205 |
site | Not glycated | | 214 | 214 |
site | Not glycated | | 219 | 219 |
site | Aspirin-acetylated lysine | | 223 | 223 |
site | Not glycated | | 229 | 229 |
site | Not glycated | | 236 | 236 |
site | Not glycated | | 264 | 264 |
site | Not glycated | | 286 | 286 |
site | Not glycated | | 298 | 298 |
site | Not glycated | | 310 | 310 |
site | Not glycated | | 383 | 383 |
site | Not glycated | | 396 | 396 |
site | Not glycated | | 413 | 413 |
site | Not glycated | | 426 | 426 |
site | Not glycated | | 438 | 438 |
site | Not glycated | | 456 | 456 |
site | Not glycated | | 460 | 460 |
site | Not glycated | | 490 | 490 |
site | Not glycated | | 499 | 499 |
site | Not glycated | | 524 | 524 |
site | Not glycated | | 543 | 543 |
site | Not glycated | | 548 | 548 |
site | Not glycated | | 562 | 562 |
site | Not glycated | | 565 | 565 |
site | Not glycated | | 581 | 581 |
site | Not glycated | | 584 | 584 |
site | Not glycated | | 588 | 588 |
site | Not glycated | | 598 | 598 |
splice variant | (in isoform 2) | | 43 | 234 |
propeptide | | | 19 | 24 |
metal ion-binding site | Copper | by similarity | 27 | 27 |
binding site | Bilirubin | potential | 264 | 264 |
turn | | | 119 | 123 |